Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn's disease: Results from induction and maintenance phase 3 trials

被引：0
|
作者：
Ghosh, S. [1 ]
Feagan, B. [2 ]
Parra, R. S. [3 ]
Lopes, S. [4 ]
Steinlauf, A. [5 ]
Kakuta, Y. [6 ]
Joshi, N. [7 ]
Lee, W. J. [7 ]
Remple, V. [7 ]
Lacerda, A. P. [7 ]
Zhou, Q. [7 ]
Xuan, S. [7 ]
Louis, E. [8 ]
机构：
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] Western Univ, London, ON, Canada
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil
[4] Ctr Hosp & Univ Sao Joao, Porto, Portugal
[5] Mt Sinai Hosp, IBD Clincal Ctr, New York, NY USA
[6] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Sendai, Miyagi, Japan
[7] AbbVie Inc, Chicago, IL USA
[8] Ctr Hosp Univ Liege, Dept Gastroenterol, Liege, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P434
引用
收藏
页码：560 / +
页数：4
相关论文
共 50 条
  • [1] UPADACITINIB IMPROVED FATIGUE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM INDUCTION AND MAINTENANCE PHASE 3 TRIALS
    Ghosh, Subrata
    Feagan, Brian G.
    Parra, Rogerio S.
    Lopes, Susana
    Steinlauf, Adam F.
    Kakuta, Yoichi
    Joshi, Namita
    Lee, Wan-Ju
    Remple, Valencia
    Lacerda, Ana P.
    Zhou, Qian
    Xuan, Si
    Louis, Edouard
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1106 - S1106
  • [2] Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease
    Ghosh, Subrata
    Feagan, Brian G.
    Parra, Rogerio Serafim
    Lopes, Susana
    Steinlauf, Adam
    Kakuta, Yoichi
    Joshi, Namita
    Lee, Wan-Ju
    Lacerda, Ana P.
    Zhou, Qian
    Xuan, Si
    Kligys, Kristina
    Shukla, Nidhi
    Louis, Edouard
    [J]. JOURNAL OF CROHNS & COLITIS, 2024,
  • [3] Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
    Panes, Julian
    Loftus, Edward, V
    Higgins, Peter D. R.
    Lindsay, James O.
    Zhou, Wen
    Yao, Xuan
    Ilo, Dapo
    Phillips, Charles
    Tran, Jacinda
    Sanchez Gonzalez, Yuri
    Vermeire, Severine
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, : 1421 - 1430
  • [4] Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease: U-ENDURE Phase 3 Results
    Panes, Julian
    Loftus, Edward, Jr.
    Lacerda, Ana
    Peyrin-Biroulet, Laurent
    D'Haens, Geert
    Panaccione, Remo
    Reinisch, Walter
    Louis, Edouard
    Chen, Minhu
    Nakase, Hiroshi
    Begun, Jakob
    Boland, Brigid
    Liu, Jianzhong
    Dubcenco, Elena
    Mohamed, Mohamed-Eslam
    Feng, Tian
    Colombel, Jean-Frederic
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S10 - S10
  • [5] Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from, 52-week phase, 3 study U ACHIEVE maintenance
    Panes, J.
    Loftus, E. V. J.
    Higgins, P.
    Lindsay, J. O.
    Zhou, W.
    Yao, X.
    Ilo, D.
    Phillips, C.
    Tran, J.
    Sanchez Gonzalez, Y.
    Vermeire, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I373 - I374
  • [6] Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from, 52-week phase, 3 study U ACHIEVE maintenance
    Panes, J.
    Loftus, E. V. J.
    Higgins, P.
    Lindsay, O.
    Zhou, W.
    Yao, X.
    Ilo, D.
    Phillips, C.
    Tran, J.
    Gonzalez, Y. Sanchez
    Vermeire, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I373 - I374
  • [7] Guselkumab Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the QUASAR Phase 3 Induction Study
    Bressler, Brian
    Feagan, Brian G.
    Panes, Julian
    Lichtenstein, Gary R.
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Pandya, Dwiti
    Han, Chenglong
    Miao, Ye
    Zhang, Hongyan
    Lateef, Syed
    Petroniene, Rima
    Rayyan, Yaser
    Peyrin-Biroulet, Laurent
    Rubin, David T.
    Hisamatsu, Tadakazu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S807 - S808
  • [8] Efficacy of Induction upadacitinib Therapy in Chinese Patients with Moderately to Severely Active Crohn's Disease
    Chen, M.
    Gao, X.
    Cao, Q.
    Zhang, X.
    Chen, Y.
    Hou, X.
    Zhong, J.
    Sun, Y.
    Phaleng, X.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1213 - I1213
  • [9] Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn's Disease: Results from a phase 3 clinical trial
    Travis, S.
    Hisamatsu, T.
    Fischer, M.
    Dubinsky, M.
    Jairath, V.
    Chen, M.
    Ferrante, M.
    Peyrin-Biroulet, L.
    Siegmund, B.
    Gibble, T. Hunter
    Lin, Z.
    Protic, M.
    Morris, N.
    Ghosh, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I21 - I23
  • [10] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease: Results From a Randomized Phase 3 U-EXCEL Study
    Loftus, Edward V.
    Colombel, Jean-Frederic
    Lacerda, Ana Paula
    Peyrin-Biroulet, Laurent
    D'Haens, Geert
    Panaccione, Remo
    Reinisch, Walter
    Louis, Edouard
    Chen, Minhu
    Nakase, Hiroshi
    Greenbloom, Susan
    DuVall, George
    Sanchez-Gonzalez, Yuri
    Mohamed, Mohamed-Eslam
    Rhee, Susan
    Feng, Tian
    Dubcenco, Elena
    Panes, Julian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S518 - S518
12345